News

Deal Announcements

CalciMedica Collects $3 Million Venture Capital Debt

Tuesday, July 16, 2013 5:32:00 AM PDT | VentureDeal
   La Jolla, California  --  Pharmaceutical company CalciMedica has secured $3 million in new venture capital debt funding, according to an SEC regulatory filing.

CalciMedica is developing drugs focused on autoimmune and inflammatory diseases.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

CalciMedica still seeking $3 million in additional financing, according to the filing. (Not a solicitation.)

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1